Last: | $87.15 |
---|---|
Change Percent: | -0.21% |
Open: | $87.1 |
Close: | $87.15 |
High: | $87.73 |
Low: | $86.93 |
Volume: | 7,210,963 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$87.15 | $87.1 | $87.15 | $87.73 | $86.93 | 7,210,963 | 03-28-2024 |
$86.92 | $84.19 | $86.92 | $87.03 | $84.1 | 8,220,106 | 03-27-2024 |
$83.7 | $83.5 | $83.7 | $83.865 | $83.05 | 4,806,870 | 03-26-2024 |
$83.24 | $82.81 | $83.24 | $83.4 | $82.72 | 5,481,262 | 03-25-2024 |
$83.08 | $83.7 | $83.08 | $83.86 | $82.93 | 5,181,488 | 03-22-2024 |
$83.41 | $83.57 | $83.41 | $83.99 | $83.09 | 6,233,826 | 03-21-2024 |
$83.35 | $83.0624 | $83.35 | $83.4889 | $82.8541 | 4,191,688 | 03-20-2024 |
$84.11 | $83.69 | $84.11 | $84.145 | $83.3 | 4,903,025 | 03-19-2024 |
$83.66 | $83.8 | $83.66 | $84.06 | $83.335 | 4,783,947 | 03-18-2024 |
$83.57 | $83.44 | $83.57 | $84.01 | $82.82 | 17,082,112 | 03-15-2024 |
$84.39 | $84.52 | $84.39 | $84.71 | $83.99 | 7,836,207 | 03-14-2024 |
$85.08 | $86.01 | $85.08 | $86.35 | $84.79 | 5,908,339 | 03-13-2024 |
$85.74 | $85.15 | $85.74 | $86.09 | $84.9002 | 4,562,160 | 03-12-2024 |
$85.5 | $84.54 | $85.5 | $85.63 | $84.54 | 5,539,055 | 03-11-2024 |
$85.13 | $85.48 | $85.13 | $86.265 | $84.92 | 6,561,312 | 03-08-2024 |
$85.15 | $86 | $85.15 | $86.43 | $84.68 | 6,177,553 | 03-07-2024 |
$85.55 | $84.73 | $85.55 | $85.8 | $84.6 | 6,048,456 | 03-06-2024 |
$84.6 | $85.44 | $84.6 | $85.84 | $84.301 | 5,073,742 | 03-05-2024 |
$85.06 | $83.6 | $85.06 | $85.11 | $83.235 | 5,553,111 | 03-04-2024 |
$83.6 | $83.42 | $83.6 | $83.845 | $82.65 | 4,266,698 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Medtronic plc. Company Name:
MDT Stock Symbol:
NYSE Market:
Tuesday, Shockwave Medical Inc (NASDAQ:SWAV) shares traded higher following a Wall Street Journal report suggesting Johnson & Jo...
Wednesday, the FDA approved Medtronic plc’s (NYSE:MDT) Evolut FX+ transcatheter aortic valve replacement (TAVR) system for symptoma...
Initiated enrollment of the BACKBEAT global pivotal study evaluating AVIM therapy (also known as BackBeat Cardiac Neuromodulation Therapy) in hypertensive pacemaker patients in collaboration with Medtronic, plc (NYSE: MDT) in December 2023 Orchestra BioMed and Terumo remain actively engag...